학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 108건 | 목록 1~10
Academic Journal
Schiemann K; Merck (Germany), Darmstadt, Germany.; Belousova N; EMD Serono, Billerica, United States.; Matevossian A; EMD Group (United States), Billerica, MA, United States.; Nallaparaju KC; EMD Group (United States), Billerica, MA, United States.; Kradjian G; EMD Serono, Billerica, MA, United States.; Pandya M; EMD Group (United States), Billerica, MA, United States.; Chen Z; EMD Group (United States), Billerica, MA, United States.; Aral E; EMD Group (United States), Billerica, MA, United States.; Krauel EM; EMD Group (United States), Billerica, MA, United States.; Petrova E; Merck, Germany.; Boesler C; Merck (Germany), Germany.; Kitzing T; Merck Healthcare KGaA, Darmstadt, Germany, Darmstadt, Germany.; Lecomte M; Merck, Darmstadt, Germany.; Wagner C; Merck, Germany.; Blayo AL; Domain Therapeutics (France), France.; Schann S; Domain Therapeutics (France), Illkirch Graffenstaden, France.; Huck B; EMD Group (United States), Billerica, MA, United States.; Moisan J; EMD Group (United States), Billerica, MA, United States.; Zaynagetdinov R; EMD Group (United States), Billerica, MA, United States.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Boje AS; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel, Germany.; Pekar L; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.; Koep K; Drug Metabolism and Pharmacokinetics, Merck Healthcare KGaA, Darmstadt, Germany.; Lipinski B; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.; Rabinovich B; Department of Oncology and Immuno-Oncology, EMD Serono Research & Development Institute Inc, 45A Middlesex Turnpike, Billerica, MA, USA.; Evers A; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.; Gehlert CL; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel, Germany.; Krohn S; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel, Germany.; Xiao Y; Department of Oncology and Immuno-Oncology, EMD Serono Research & Development Institute Inc, 45A Middlesex Turnpike, Billerica, MA, USA.; Krah S; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.; Zaynagetdinov R; Department of Oncology and Immuno-Oncology, EMD Serono Research & Development Institute Inc, 45A Middlesex Turnpike, Billerica, MA, USA.; Toleikis L; Early Protein Supply & Characterization, Merck Healthcare KGaA, Darmstadt, Germany.; Poetzsch S; Strategic Innovation, Merck Healthcare KGaA, Darmstadt, Germany.; Peipp M; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel, Germany.; Zielonka S; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.; Klausz K; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel, Germany.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Academic Journal
Klausz K; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein and Christian Albrechts University Kiel, Kiel, Germany.; Pekar L; Protein Engineering and Antibody Technologies, Merck Healthcare KGaA, Darmstadt, Germany.; Boje AS; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein and Christian Albrechts University Kiel, Kiel, Germany.; Gehlert CL; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein and Christian Albrechts University Kiel, Kiel, Germany.; Krohn S; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein and Christian Albrechts University Kiel, Kiel, Germany.; Gupta T; Protein Engineering and Antibody Technologies, EMD Serono Research & Development Institute, Inc., Billerica, MA.; Xiao Y; Department of Oncology and Immuno-oncology, EMD Serono Research & Development Institute, Inc., Billerica, MA.; Krah S; Protein Engineering and Antibody Technologies, Merck Healthcare KGaA, Darmstadt, Germany.; Zaynagetdinov R; Department of Oncology and Immuno-oncology, EMD Serono Research & Development Institute, Inc., Billerica, MA.; Lipinski B; Protein Engineering and Antibody Technologies, Merck Healthcare KGaA, Darmstadt, Germany.; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany; and.; Toleikis L; Protein Engineering and Antibody Technologies, Merck Healthcare KGaA, Darmstadt, Germany.; Poetzsch S; Strategic Innovation, Merck Healthcare KGaA, Darmstadt, Germany.; Rabinovich B; Department of Oncology and Immuno-oncology, EMD Serono Research & Development Institute, Inc., Billerica, MA.; Peipp M; Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein and Christian Albrechts University Kiel, Kiel, Germany; matthias.peipp@uksh.de stefan.zielonka@merckgroup.com.; Zielonka S; Protein Engineering and Antibody Technologies, Merck Healthcare KGaA, Darmstadt, Germany; matthias.peipp@uksh.de stefan.zielonka@merckgroup.com.; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany; and.
Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Zaynagetdinov, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어